Actor Eric Dane Dies from ALS at 53

The 'Grey's Anatomy' and 'Euphoria' star succumbed to the rare and fatal nervous system disease less than a year after his diagnosis.

Feb. 20, 2026 at 9:45pm by Ben Kaplan

Got story updates? Submit your updates here. ›

Eric Dane, known for his roles on the hit TV shows 'Grey's Anatomy' and 'Euphoria', passed away this week at the age of 53 due to amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The fatal nervous system condition causes the loss of muscle control and leads to paralysis, with most patients surviving just 2-5 years after symptom onset.

Why it matters

ALS is a relatively rare disease, with only around 33,000 estimated cases in the U.S. in 2022. However, the number of ALS patients is projected to rise to over 36,000 by 2030 as the population ages. Dane's high-profile death from the disease raises awareness and understanding of this debilitating condition.

The details

ALS affects the nerve cells in the brain and spinal cord, causing them to stop working and die. This leads to a loss of muscle control and eventual paralysis, impacting mobility, speech, swallowing and breathing. There is no known cure for ALS, though some medications like riluzole can modestly extend survival in early stages. Most ALS patients pass away within 2-5 years of symptom onset, usually due to respiratory failure.

  • Eric Dane announced his ALS diagnosis less than a year ago.
  • Dane died this week at the age of 53.

The players

Eric Dane

A popular American actor known for his roles on the TV shows 'Grey's Anatomy' and 'Euphoria', who passed away at age 53 due to amyotrophic lateral sclerosis (ALS).

Lou Gehrig

A Hall of Fame baseball player for the New York Yankees who was diagnosed with ALS in 1939 and became the face of the disease for decades.

Got photos? Submit your photos here. ›

What they’re saying

“ALS is a devastating disease that robs people of their ability to move, speak, swallow and ultimately breathe. Eric Dane's passing is a tragic reminder of the urgent need for more research and effective treatments.”

— Dr. Lucie Bruijn, Chief Scientist, ALS Association

What’s next

Researchers continue to study potential new treatments for ALS, with the goal of slowing disease progression and extending survival. The ALS Association and other advocacy groups will likely increase efforts to raise awareness and funding for ALS research in the wake of Dane's high-profile death.

The takeaway

Eric Dane's untimely passing from ALS at just 53 years old underscores the devastating impact of this rare but fatal neurological disease. His story will hopefully inspire greater public understanding and support for ALS research to develop more effective therapies and cures.